Sanofi Consumer Healthcare India: Should You Buy, Hold, or Sell Right Now?
- September 3, 2026
- Posted by: Lakshit Sharma
- Category: Market
Sanofi Consumer Healthcare share price Rs 4,170.70 (NSE), roughly flat today. 52-week range Rs 3,950.50 to Rs 5,394. Very high return on equity of 76.46%.
Quick Answer
Sanofi Consumer Healthcare India Ltd share price is trading around Rs 4,171, roughly 23 percent below its 52-week high of Rs 5,394 but above its 52-week low of Rs 3,950.50. This is an extremely thinly traded stock, with typical daily volumes of only a few hundred shares, and specific Q1 FY27 quarterly figures were not independently confirmed across public sources at the time of writing. Based on available annual-level data, the company shows an exceptionally high return on equity of 76.46 percent and trades at 36.4 times earnings, a discount to the broader consumer healthcare sector average near 51 times. Given the very low trading liquidity, investors should be especially mindful of execution challenges when considering this stock.
Sanofi Consumer Healthcare share price is trading around Rs 4,171 on the NSE, roughly 23 percent below its 52-week high of Rs 5,394 and above its 52-week low of Rs 3,950.50. Given the extremely limited trading volumes and unconfirmed recent quarterly figures, this article presents what is reliably known about the company’s valuation and financial profile, with appropriate caveats about data availability.
This Sanofi Consumer Healthcare India overview walks through the available valuation metrics, shareholding pattern and the technical setup, using figures sourced from company disclosures and public filings, while being transparent about the specific data gaps for this thinly traded stock.
Click Here – Get Free Investment Predictions
About Sanofi Consumer Healthcare India
Keep this backdrop in mind when reading the rest of this Sanofi Consumer Healthcare share price review. Before deciding on Sanofi Consumer Healthcare share price, it helps to understand the underlying business. Sanofi Consumer Healthcare India Ltd. is the India-listed consumer healthcare arm of the global Sanofi group, focused on over-the-counter and consumer health products in the Indian market. As with many multinational consumer healthcare subsidiaries listed in India, the stock has a relatively small public float and correspondingly low trading liquidity.
The company’s exceptionally high return on equity reflects the asset-light, brand-driven nature of the consumer healthcare business, though the very low trading volumes mean that price movements on this stock should be interpreted with additional caution relative to more actively traded names.
Sanofi Consumer Healthcare India Share Price Today: Key Levels
This snapshot is the starting point for any Sanofi Consumer Healthcare share price discussion. The table below summarises where Sanofi Consumer Healthcare share price stands right now against its recent trading range and market value.
| Metric | Value |
|---|---|
| Sanofi Consumer Healthcare CMP (NSE) | Rs 4,170.70 |
| Sanofi Consumer Healthcare CMP (BSE) | Rs 4,189.55 |
| 52-Week High | Rs 5,394.00 |
| 52-Week Low | Rs 3,950.50 |
| Market Capitalisation | Approximately Rs 9,673 crore |
| NSE Volume (latest session) | 221 shares (very low liquidity) |
Sanofi Consumer Healthcare share price trades with very low daily volumes, a common feature of multinational consumer healthcare subsidiaries with small public floats listed in India.
Check the Univest Screener for Live Stock Data
Sanofi Consumer Healthcare India Financial Performance
These figures anchor the rest of this Sanofi Consumer Healthcare share price review. Track this line item closely if you are following Sanofi Consumer Healthcare share price closely. The Sanofi Consumer Healthcare share price trend is closely tied to how these numbers evolve each quarter. Specific Q1 FY27 quarterly revenue and profit figures for Sanofi Consumer Healthcare India were not independently confirmed across public sources at the time of writing, given the stock’s limited analyst and media coverage relative to more widely tracked names. Based on available trailing twelve-month data, the company reported earnings per share of Rs 115.50.
Investors interested in more granular quarterly results should refer directly to the company’s exchange filings, since third-party financial data providers appear to have limited coverage of this particular stock’s quarterly reporting cadence.
| Period | Revenue | Net Profit | Comment |
|---|---|---|---|
| Trailing twelve months | Not independently confirmed | EPS Rs 115.50 | Specific Q1 FY27 quarterly figures not confirmed across sources |
Valuation Check: Is Sanofi Consumer Healthcare India Share Price Expensive?
This context matters for anyone assessing Sanofi Consumer Healthcare share price today. It is one of the clearest signals available on Sanofi Consumer Healthcare share price today. Any view on Sanofi Consumer Healthcare share price should start from these valuation multiples. Sanofi Consumer Healthcare share price currently reflects a price to earnings ratio of about 36.4 times trailing earnings, a discount to the broader consumer healthcare sector average of roughly 51.2 times. The price to book ratio stands at a rich 27.8 times, supported by an exceptionally high return on equity of 76.46 percent.
Debt to equity of 0.06 is very low, and the stock offers a dividend yield of 1.78 percent. Historically, multinational consumer healthcare subsidiaries with strong brand portfolios and asset-light business models have commanded premium price to book ratios reflecting their high return on equity, consistent with what is seen here.
Technical Signals: What the Chart Shows
Watching Sanofi Consumer Healthcare share price over consecutive sessions gives a clearer read than any single print. Price action here often foreshadows the next move in Sanofi Consumer Healthcare share price. Sanofi Consumer Healthcare share price is currently positioned about 23 percent below its 52-week high of Rs 5,394 and roughly 6 percent above its 52-week low of Rs 3,950.50, placing it in the lower half of its annual trading range. Given the very low trading volumes on this stock, typically only a few hundred shares per session, price movements should be interpreted with more caution than for actively traded stocks.
Investors considering this stock should be aware that the low liquidity can make it harder to execute trades at desired prices, and should track any available company disclosures rather than relying solely on technical price patterns at these levels.
Download the Univest iOS App or Univest Android App to track Sanofi Consumer Healthcare India’s live price and technical levels.
Shareholding Pattern
This detail is a useful reference point for Sanofi Consumer Healthcare share price discussions. Shifts here can influence Sanofi Consumer Healthcare share price more than headline news on some sessions. Sanofi Consumer Healthcare India is majority owned by the global Sanofi group as its India-listed consumer healthcare subsidiary. A detailed current institutional and public shareholding percentage breakdown was not consistently available across sources at the time of writing and should be verified on the company’s latest exchange filing.
Why Investors Are Watching Sanofi Consumer Healthcare India
- Exceptionally high return on equity: A 76.46 percent ROE reflects the highly capital-efficient, brand-driven nature of the consumer healthcare business.
- Valuation discount to sector on PE basis: A 36.4x PE against a 51.2x consumer healthcare sector average offers some relative valuation appeal, notwithstanding the rich price to book ratio.
- Global Sanofi brand backing: As part of the global Sanofi group, the company benefits from access to established international consumer healthcare brands and product development.
- Attractive dividend yield: A 1.78 percent dividend yield adds an income component for long-term shareholders of this asset-light business.
Risks and Factors to Watch
- Very low trading liquidity: With daily volumes often in the low hundreds of shares, this stock can be difficult to trade at desired prices, and price discovery may be less efficient than for actively traded names.
- Limited data availability: Specific quarterly figures for the most recent period were not independently confirmed across public sources, requiring investors to rely more heavily on direct company filings.
- Rich price to book ratio: A 27.8 times price to book ratio, while consistent with the high ROE, still represents a premium valuation on a per-asset basis.
- Small public float dynamics: As with many multinational subsidiary listings, a small public float can lead to more volatile price behaviour on relatively modest trading volumes.
Sanofi Consumer Healthcare India Share Price Target: What the Data Suggests
Until then, Sanofi Consumer Healthcare share price remains best tracked through live, verified data rather than a single fixed number. Sanofi Consumer Healthcare India does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time, given the stock’s limited analyst coverage and trading liquidity.
Investors interested in this stock should refer directly to company exchange filings for the most reliable quarterly information, and should consult a SEBI-registered investment adviser given the limited data availability and low liquidity involved.
Sanofi Consumer Healthcare India: Should You Buy, Hold, or Sell Right Now?
There is no shortcut here: Sanofi Consumer Healthcare share price needs to be judged against your own plan. This is the core question behind Sanofi Consumer Healthcare share price right now. The Sanofi Consumer Healthcare India buy or sell decision should account for the stock’s limited liquidity and data availability as much as its underlying business quality.
The case for buying: Investors who value the exceptionally high return on equity and global Sanofi brand backing, and who are comfortable with low trading liquidity, may find the current valuation discount to the consumer healthcare sector attractive.
The case for holding: Existing shareholders who already understand this stock’s liquidity characteristics may prefer to stay invested as a long-term holding given the strong underlying business economics.
The case for trimming or waiting: Investors who prioritise easily tradable, well-covered stocks with readily available quarterly data may prefer to look elsewhere given this stock’s limited liquidity and coverage.
Given the limited data availability, consult a SEBI-registered investment adviser and review the company’s direct filings before making any decision on this stock.
Conclusion
In short, Sanofi Consumer Healthcare share price calls for weighing these points together rather than in isolation. Sanofi Consumer Healthcare share price reflects a highly capital-efficient, brand-driven consumer healthcare subsidiary of the global Sanofi group, trading at a discount to the sector on a PE basis but with very low trading liquidity and limited publicly confirmed quarterly data. Whether that makes the stock a buy, a hold or a sell right now depends significantly on your comfort with these liquidity and data constraints. This article is for informational purposes and not a personalised investment recommendation.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Q1. Is Sanofi Consumer Healthcare India a good stock to buy right now?
Ans. Sanofi Consumer Healthcare India shows an exceptionally high 76.46 percent return on equity and trades at a discount to the consumer healthcare sector on a PE basis, but the stock has very low trading liquidity and limited publicly confirmed recent quarterly data, which investors should factor into any decision.
Q2. What is the Sanofi Consumer Healthcare share price today?
Ans. Sanofi Consumer Healthcare share price is trading around Rs 4,171 on the NSE. The stock’s 52-week high is Rs 5,394 and its 52-week low is Rs 3,950.50.
Q3. What is the Sanofi Consumer Healthcare share price target?
Ans. Sanofi Consumer Healthcare India does not have a single widely published, current analyst consensus 12-month share price target consistently available at this time, given the stock’s limited analyst coverage. Investors should consult a SEBI-registered adviser and review company filings directly.
Q4. Why is Sanofi Consumer Healthcare India stock so illiquid?
Ans. Sanofi Consumer Healthcare India, as the India-listed consumer healthcare subsidiary of the global Sanofi group, has a small public float typical of many multinational subsidiary listings, resulting in daily trading volumes often in the low hundreds of shares.
Q5. What is Sanofi Consumer Healthcare India’s market capitalisation and PE ratio?
Ans. Sanofi Consumer Healthcare India has a market capitalisation of approximately Rs 9,673 crore and trades at a price to earnings ratio of about 36.4 times, a discount to the consumer healthcare sector average PE of roughly 51.2 times.
Q6. Does Sanofi Consumer Healthcare India pay a dividend?
Ans. Yes, Sanofi Consumer Healthcare India offers a dividend yield of approximately 1.78 percent, reflecting a shareholder return policy consistent with its asset-light, high-return consumer healthcare business model.